LENZ Therapeutics, Inc. (LENZ) vs Lucid Diagnostics Inc. (LUCD)
A side-by-side comparison of LENZ Therapeutics, Inc. and Lucid Diagnostics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LENZ
LENZ Therapeutics, Inc.
$3.73HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
LUCD
Lucid Diagnostics Inc.
$0.61HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — LENZ vs LUCD
growth of $100 · dividends reinvested · last 5yLENZ -87.5% (-34.1%/yr)LUCD -95.0% (-45.0%/yr)LENZ compounded faster over this window
LENZ LUCD
LENZ vs LUCD: by the numbers
- •LENZ is the larger company ($117M vs $116M market cap).
- •Both run net losses; LENZ's is the smaller (-586.74% vs -959.76% net margin).
Metrics side by side
Valuation
| Metric | LENZ | LUCD |
|---|---|---|
| P/S ratio | 5.45 | 21.22 |
| P/B ratio | 0.53 | 10.58 |
Profitability
| Metric | LENZ | LUCD |
|---|---|---|
| Gross margin | 90.14% | -60.26% |
| Operating margin | -477.46% | -1054.82% |
| Net margin | -586.74% | -959.76% |
| ROE | -57.47% | -478.26% |
| ROIC | -61.84% | -145.10% |
Growth (annualized)
| Metric | LENZ | LUCD |
|---|---|---|
| Total return CAGR (5Y) | -35.49% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.